Feedback / Questions
NG-350A - Akamis Bio
https://www.businesswire.com/news/home/20250403722186/en/Akamis-Bio-Announces-Enrollment-of-First-Patient-in-Phase-1b-FORTRESS-Trial-of-NG-350A-in-Patients-with-Locally-Advanced-Rectal-Cancer
Apr 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next